Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
LA JOLLA PHARMACEUTICAL CO (LJPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/01/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/29/2022 |
SC 13D/A
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in La Jolla Pharmaceutical Co. |
| 08/29/2022 |
SC 13D
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 6% stake in La Jolla Pharmaceutical Co. |
| 08/24/2022 |
4
| Rosen Robert (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 18,000 options to buy
@ $8.52, valued at
$153.4k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| RAMSAY DAVID A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 100,000 shares
@ $6.23, valued at
$623k
Disposed/sold 18,000 options to buy
@ $8.43, valued at
$151.7k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Disposed/sold 18,000 options to buy
@ $9.2, valued at
$165.6k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
4
| Edwards Larry G. (CEO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 11,969 shares
@ $6.23, valued at
$74.6k
Disposed/sold 400,000 options to buy
@ $3.89, valued at
$1.6M
Disposed/sold 278,350 options to buy
@ $4.53, valued at
$1.3M
Disposed/sold 322 options to buy
@ $4.18, valued at
$1.3k
Disposed/sold 304 options to buy
@ $4.44, valued at
$1.3k
Disposed/sold 358 options to buy
@ $3.76, valued at
$1.3k
Disposed/sold 314 options to buy
@ $4.3, valued at
$1.4k
Disposed/sold 275 options to buy
@ $4.9, valued at
$1.3k
Disposed/sold 315 options to buy
@ $4.28, valued at
$1.3k
Disposed/sold 374 options to buy
@ $3.61, valued at
$1.4k
Disposed/sold 338 options to buy
@ $3.98, valued at
$1.3k
|
|
| 08/24/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 1,675 options to buy
@ $4.63, valued at
$7.8k
Disposed/sold 169 options to buy
@ $4.46, valued at
$753.7
Disposed/sold 185 options to buy
@ $4.09, valued at
$756.7
Disposed/sold 177 options to buy
@ $4.27, valued at
$755.8
Disposed/sold 173 options to buy
@ $4.37, valued at
$756
Disposed/sold 185 options to buy
@ $4.08, valued at
$754.8
Disposed/sold 236 options to buy
@ $3.2, valued at
$755.2
Disposed/sold 236 options to buy
@ $3.19, valued at
$752.8
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 500 shares
@ $6.23, valued at
$3.1k
Disposed/sold 13,500 options to buy
@ $6, valued at
$81k
Disposed/sold 13,000 options to buy
@ $10.84, valued at
$140.9k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 12,000 shares
@ $6.23, valued at
$74.8k
Disposed/sold 18,000 options to buy
@ $6, valued at
$108k
Disposed/sold 19,000 options to buy
@ $10.84, valued at
$206k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 30,000 options to buy
@ $5.25, valued at
$157.5k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 08/24/2022 |
4
| Hearne Michael S (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 10,186 shares
@ $6.23, valued at
$63.5k
Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Disposed/sold 100,000 options to buy
@ $4.55, valued at
$455k
Disposed/sold 169 options to buy
@ $3.91, valued at
$660.8
Disposed/sold 196 options to buy
@ $3.4, valued at
$666.4
Disposed/sold 141 options to buy
@ $4.68, valued at
$659.9
Disposed/sold 134 options to buy
@ $4.97, valued at
$666
Disposed/sold 52,191 options to buy
@ $4.53, valued at
$236.4k
Disposed/sold 147 options to buy
@ $4.5, valued at
$661.5
Disposed/sold 1,648 options to buy
@ $3.88, valued at
$6.4k
Disposed/sold 136 options to buy
@ $5.35, valued at
$727.6 |
|
| 08/24/2022 |
4
| TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Unknown transaction of 9,607,934 shares
@ $6.23, valued at
$59.9M
Unknown transaction of 3,519 options to buy
@ $0 |
|
| 08/24/2022 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in La Jolla Pharmaceutical Company |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/22/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 08/22/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/22/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/16/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/15/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/25/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 07/25/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 07/12/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Exercised 12,000 options to buy
@ $3.93, valued at
$47.2k
|
|
| 07/12/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 07/11/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/11/2022 |
8-K
| Quarterly results |
|
|
|